Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5695088 | Gynecologic Oncology | 2017 | 5 Pages |
Abstract
Intrauterine levonorgestrel is a viable treatment option for post-menopausal women with AH/EC who are poor candidates for standard surgical management. The response rate in this series is similar to published reports in premenopausal patients and includes cases of disease recurrence following conversion to benign endometrium.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
William D. Baker, Stuart R. Pierce, Anne M. Mills, Paola A. Gehrig, Linda R. Duska,